3Filing Date: Aug 28, 2026

Pfizer (PFE)

Initial Statement of Beneficial Ownership

View SEC Filing
ACC: 0001225208-26-007363
Total Value$0
Trades2
Insiders1

Transaction Details

Guegan Cecile
Executive Vice President·Direct
Stock Appreciation RightsDerivative
Shares0
Price-
Total Value$0
Exercise Price$25.75
ExpiresMar 4, 2030
Holding Only
Footnotes ▸

The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. | The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

Guegan Cecile
Executive Vice President·Direct
Common Stock
Shares0
Price-
Total Value$0
Shares Owned After149.50K

Post-Transaction Holdings

Guegan Cecile · Executive Vice President
SecuritySharesChange
Common Stock149.50K-
Stock Appreciation Rights--
Original SEC Filing Textexpand_more
=== SEC Form 3 — Statement of Changes in Beneficial Ownership === Document Type: 3 Period of Report: 2026-08-17 --- Issuer --- Name: PFIZER INC (PFE) CIK: 0000078003 --- Reporting Owner --- Name: Guegan Cecile CIK: 0002151218 Role: Officer (Executive Vice President) --- Holdings --- [Holding #1] Security: Common Stock Ownership: D (Direct) [Holding #2] Security: Stock Appreciation Rights Ownership: D (Direct) Footnotes: [F1] The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. [F1] The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. [Holding #3] Security: Stock Appreciation Rights Ownership: D (Direct) Footnotes: [F1] The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. [F1] The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. [Holding #4] Security: Stock Appreciation Rights Ownership: D (Direct) Footnotes: [F1] The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. [F1] The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. [Holding #5] Security: Stock Appreciation Rights Ownership: D (Direct) Footnotes: [F2] The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. [F2] The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. [Holding #6] Security: Stock Appreciation Rights Ownership: D (Direct) Footnotes: [F2] The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. [F2] The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. [Holding #7] Security: Stock Appreciation Rights Ownership: D (Direct) Footnotes: [F2] The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. [F2] The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. [Holding #8] Security: Stock Appreciation Rights Ownership: D (Direct) Footnotes: [F2] The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. [F2] The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. [Holding #9] Security: Stock Appreciation Rights Ownership: D (Direct) Footnotes: [F2] The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. [F2] The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. [Holding #10] Security: Stock Appreciation Rights Ownership: D (Direct) Footnotes: [F2] The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. [F2] The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. [Holding #11] Security: Stock Appreciation Rights Ownership: D (Direct) Footnotes: [F2] The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. [F2] The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. --- Footnotes (Complete Index) --- F1: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F2: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. --- Signature --- /s/ /s/ Shanice A. Reid, by power of atty, for Cecile Guegan (2026-08-27)

keid analysis is for reference only and does not constitute investment advice.